MedPath

Institute of Oncology Ljubljana

🇸🇮Slovenia
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.onko-i.si/

Clinical Trials

39

Active:7
Completed:14

Trial Phases

4 Phases

Phase 1:5
Phase 2:13
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (27 trials with phase data)• Click on a phase to view related trials

Phase 2
13 (48.1%)
Not Applicable
8 (29.6%)
Phase 1
5 (18.5%)
Phase 3
1 (3.7%)

Effect of Lidocaine or Dexamethasone on Cancer Immune Response- the PILDI Study

Phase 3
Not yet recruiting
Conditions
Colon Cancer
Interventions
First Posted Date
2025-04-11
Last Posted Date
2025-04-11
Lead Sponsor
Institute of Oncology Ljubljana
Target Recruit Count
90
Registration Number
NCT06923787
Locations
🇸🇮

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer

Recruiting
Conditions
Breast Cancer
Radiotherapy Side Effect
First Posted Date
2024-10-18
Last Posted Date
2024-10-18
Lead Sponsor
Institute of Oncology Ljubljana
Target Recruit Count
200
Registration Number
NCT06648148
Locations
🇸🇮

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma

Not Applicable
Conditions
Cutaneous Malignant Melanoma
First Posted Date
2024-04-29
Last Posted Date
2024-04-29
Lead Sponsor
Institute of Oncology Ljubljana
Target Recruit Count
10
Registration Number
NCT06388252
Locations
🇸🇮

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

Not Applicable
Active, not recruiting
Conditions
PET CT
Melanoma
First Posted Date
2024-01-17
Last Posted Date
2024-01-17
Lead Sponsor
Institute of Oncology Ljubljana
Target Recruit Count
70
Registration Number
NCT06207747
Locations
🇸🇮

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers

Not Applicable
Recruiting
Conditions
Trace Element Deficiency
First Posted Date
2023-09-29
Last Posted Date
2024-10-17
Lead Sponsor
Institute of Oncology Ljubljana
Target Recruit Count
20
Registration Number
NCT06060990
Locations
🇸🇮

Institute of Oncology Ljubljana, Ljubljana, Slovenia

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath